Midwest Clinical Research Center, LLC
Dayton, Ohio 45417
0 studies enrolling now · 16 studies all time
What they study most
ADHD, Analgesia, Binge Eating Disorder, Depressive Disorder, Major, Knee Osteoarthritis, Major Depressive Disorder, Opioid Use Disorder, Pain Management, Schizophrenia
Studies at this site
- Study of Post-Herniorrhaphy Non-opioid MMA Regimens — Completed
- Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen — Completed
- Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder — Completed
- Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty — Completed
- KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD — Completed
- SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder — Completed
- Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD) — Stopped early
- Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder — Completed
- A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder — Completed
- A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01) — Completed
- Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension) — Completed
- Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients — Completed
- Study of NSI-189 for Major Depressive Disorder — Status unconfirmed
- An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia — Stopped early
- Lurasidone Low-Dose - High-Dose Study Study — Completed
- Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder — Completed